Flavanones protect from arterial stiffness in postmenopausal women consuming grapefruit juice for 6 mo: A randomized, controlled, crossover trial

American Journal of Clinical Nutrition

Volumn 102, Issue 1, 2015, Pages 66-74

  Habauzit, Véronique ^a,b,c   Verny, Marie Anne ^a,b   Milenkovic, Dragan ^a,b   Barber Chamoux, Nicolas ^a,d   Mazur, Andrzej ^a,b   Dubray, Claude ^c   Morand, Christine ^a,b  

^a CEMAGREF   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c INSERM   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Clinical trial; Dietary flavanones; Grapefruit juice; Postmenopausal women; Vascular function

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIN 1; FLAVANONE DERIVATIVE; INTERLEUKIN 6; NITRATE REDUCTASE; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER; NARINGENIN;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BIOCHEMICAL ANALYSIS; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DIETARY COMPLIANCE; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRAPEFRUIT JUICE; HUMAN; HUMAN EXPERIMENT; MICROCIRCULATION; NORMAL HUMAN; OXIDATIVE STRESS; PERIPHERAL ARTERIAL TONOMETRY; POSTMENOPAUSE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; BEVERAGE; BLOOD; CALORIC INTAKE; CHEMISTRY; DRUG EFFECTS; FOLLOW UP; GRAPEFRUIT; METABOLISM; MIDDLE AGED;

CITRUS; CITRUS X PARADISI;

AGED; BEVERAGES; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; BRACHIAL ARTERY; CITRUS PARADISI; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENERGY INTAKE; FEMALE; FLAVANONES; FOLLOW-UP STUDIES; HEALTHY VOLUNTEERS; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84937510096     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.114.104646     Document Type: Article

References (44)

1. Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, Hu FB. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ 2014;349:g4490.
2. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 2013;18:1818-92.
3. Pérez-Jiménez J, Fezeu L, Touvier M, Arnault N, Manach C, Hercberg S, Galan P, Scalbert A. Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr 2011;93:1220-8.
4. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr 2012;95:454-64.
5. Zamora-Ros R, Forouhi NG, Sharp SJ, Gonzalez CA, Buijsse B, Guevara M, van der Schouw YT, Amiano P, Boeing H, Bredsdorff L, et al. Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations. J Nutr 2014;144:335-43.
6. Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB, Cassidy A. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr 2012;95:740-51.
7. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008;88:38-50.
8. van Dam RM, Naidoo N, Landberg R. Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr Opin Lipidol 2013;24:25-33.
9. Chanet A, Milenkovic D, Manach C, Mazur A, Morand C. Citrus flavanones: what is their role in cardiovascular protection? J Agric Food Chem 2012;60:8809-22.
10. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR Jr. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007; 85:895-909.
11. Cassidy A, Rimm EB, O'Reilly EJ, Logroscino G, Kay C, Chiuve SE, Rexrode KM. Dietary flavonoids and risk of stroke in women. Stroke 2012;43:946-51.
12. Morand C, Dubray C, Milenkovic D, Lioger D, Martin JF, Scalbert A, Mazur A. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr 2011;93:73-80.
13. Rizza S, Muniyappa R, Iantorno M, Kim JA, Chen H, Pullikotil P, Senese N, Tesauro M, Lauro D, Cardillo C, et al. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab 2011;96:E782-92.
14. Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, et al. The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective. J Clin Pharmacol 2003;43:443-69.
15. Lührmann PM, Herbert BM, Gaster C, Neuhauser-Berthold M. Validation of a self-administered 3-day estimated dietary record for use in the elderly. Eur J Nutr 1999;38:235-40.
16. Le Moullec N, Deheeger M, Preziosi P, Montero P, Valeix P, Rolland-Cachera MF. Validation du manuel-photos utilisé pour l'enquete alimentaire de l'étude SU.VI.MAX. [Validation of the pictures' booklet of the SU.VI.MAX dietary survey.] Cahier Nutr Diet 1996;31: 158-64 (in French).
17. Hercberg S. Table de composition SU.VI.MAX des aliments. [SU.VI. MAX food composition table]. Paris (France): Les éditions INSERM/Economica; 2005 (in French).
18. Zitron E, Scholz E, Owen RW, Luck S, Kiesecker C, Thomas D, Kathofer S, Niroomand F, Kiehn J, Kreye VA, et al. QTc prolongation by grapefruit juice and its potential pharmacological basis: HERG channel blockade by flavonoids. Circulation 2005;111:835-8.
19. Albanese CV, Diessel E, Genant HK. Clinical applications of body composition measurements using DXA. J Clin Densitom 2003;6:75-85.
20. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996;239:70-6.
21. Huang D, Ou B, Hampsch-Woodill M, Flanagan JA, Prior RL. Highthroughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format. J Agric Food Chem 2002;50:4437-44.
22. Tessier F, Birlouez-Aragon I, Tjani C, Guilland JC. Validation of a micromethod for determining oxidized and reduced vitamin C in plasma by HPLC-fluorescence. Int J Vitam Nutr Res 1996;66:166-70.
23. Jones B, Kenward MG. Design and analysis of cross-over trials. II ed. Boca Raton (FL): Chapman & Hall/CRC; 2003.
24. Schulz KF, Grimes D. Multiplicity in randomised trials I: endpoints and treatments. Lancet 2005;365:1591-5.
25. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
26. Liu K, Xing A, Chen K, Wang B, Zhou R, Chen S, Xu H, Mi M. Effect of fruit juice on cholesterol and blood pressure in adults: a meta-analysis of 19 randomized controlled trials. PLoS ONE 2013; 8:e61420.
27. Ray S, Miglio C, Eden T, Del Rio D. Assessment of vascular and endothelial dysfunction in nutritional studies. Nutr Metab Cardiovasc Dis 2014;24:940-6.
28. Lilamand M, Kelaiditi E, Guyonnet S, Antonelli Incalzi R, Raynaud-Simon A, Vellas B, Cesari M. Flavonoids and arterial stiffness: promising perspectives. Nutr Metab Cardiovasc Dis 2014;24: 698-704.
29. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003;107:2864-9.
30. Curtis PJ, Potter J, Kroon PA, Wilson P, Dhatariya K, Sampson M, Cassidy A. Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial. Am J Clin Nutr 2013;97:936-42.
31. Dohadwala MM, Holbrook M, Hamburg NM, Shenouda SM, Chung WB, Titas M, Kluge MA, Wang N, Palmisano J, Milbury PE, et al. Effects of cranberry juice consumption on vascular function in patients with coronary artery disease. Am J Clin Nutr 2011;93: 934-40.
32. Teede HJ, McGrath BP, DeSilva L, Cehun M, Fassoulakis A, Nestel PJ. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 2003;23: 1066-71.
33. Nestel P, Fujii A, Zhang L. An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women. Atherosclerosis 2007;192:184-9.
34. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588-605.
35. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318-27.
36. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 2005;45:1050-5.
37. Wilkinson IB, Qasem A, McEniery CM,Webb DJ, Avolio AP, Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002;105:213-7.
38. Diebolt M, Andriantsitohaina R. Wine polyphenols modulate calcium handling in rat aorta: involvement of nitric oxide pathway. Fundam Clin Pharmacol 2002;16:289-96.
39. Speroni F, Rebolledo A, Salemme S, Roldan-Palomo R, Rimorini L, Anon MC, Spinillo A, Tanzi F, Milesi V. Genistein effects on Ca2+ handling in human umbilical artery: inhibition of sarcoplasmic reticulum Ca2+ release and of voltage-operated Ca2+ channels. J Physiol Biochem 2009;65:113-24.
40. Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, Croft KD. Pure dietary flavonoids quercetin and (2)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 2008;88:1018-25.
41. Brett GM, Hollands W, Needs PW, Teucher B, Dainty JR, Davis BD, Brodbelt JS, Kroon PA. Absorption, metabolism and excretion of flavanones from single portions of orange fruit and juice and effects of anthropometric variables and contraceptive pill use on flavanone excretion. Br J Nutr 2009;101:664-75.
42. Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, Remesy C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr 2003;57:235-42.
43. Wang B, Liu K, Mi M, Wang J. Effect of fruit juice on glucose control and insulin sensitivity in adults: a meta-analysis of 12 randomized controlled trials. PLoS ONE 2014;9:e95323.
44. Guo LQ, Fukuda K, Ohta T, Yamazoe Y. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab Dispos 2000;28:766-71.